N/A
Completed N=68
Optimal Management of Vasa Previa Study - A Retrospective Study
Vasa Previa
Source: ClinicalTrials.gov NCT01977040 ↗
Enrolled (actual)
68
Serious AEs
—
Results posted
Jan 2019
Primary outcomePrimary: Diagnostic Profile of Techniques Utilized to Screen for and Diagnose Vasa Previa During Pregnancy. — 47; 13; 4; 2 Participants
Summary
This is a multicenter retrospective observational study of women diagnosed with a vasa previa during pregnancy or at delivery who delivered between 2000 and 2012. The study hopes to be able to describe techniques utilized to screen for and diagnose vasa previa as well as to describe the maternal characteristics and identify potential underlying risk factors that may provide a basis for future screening recommendations for vasa previa and treatment protocols.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Diagnostic Profile of Techniques Utilized to Screen for and Diagnose Vasa Previa During Pregnancy. |
47; 13; 4; 2 | — |
| PRIMARY Gestational Age at Time of Diagnosis Stratified by Diagnostic Profile. |
27.0; 27.8; 19.8 | — |
| PRIMARY Mode of Delivery Stratified by Diagnostic Profile. |
7; 40; 2; 2; 9; 2 | — |
| PRIMARY Gestational Age of Infant at Birth |
34.76; 34.68; 31.50; 34.78; 37.04; 36.14 | — |
Eligibility Criteria
Inclusion Criteria
- Patients with the diagnosed of vasa previa made either during the pregnancy via ultrasound or at time of delivery via clinical and/or pathologic investigation.
- Patient delivered between January 2000 through December 2012
Exclusion Criteria
- No diagnosis or confirmation of vasa previa
- Delivered either before January 1, 2000 or after December 31, 2012
Data sourced from ClinicalTrials.gov (NCT01977040). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.